Profil
Oliver Szolar is the founder of two companies.
He is the Chief Executive Officer of a:head bio AG since 2019 and is the Chairman-Supervisory Board of HeartBeat.bio AG.
Postes actifs de Oliver Szolar
| Sociétés | Poste | Début |
|---|---|---|
a:head bio AG
 a:head bio AG Miscellaneous Commercial ServicesCommercial Services a:head bio AG engages in the research in as well as development and marketing of products in the pharmaceutical and biotechnology sectors. Its business activities focus on the development of new therapeutics for the treatment of brain disorders based on human cerebral organoids. The company was founded by Oliver Szolar, Jürgen Knoblich, and Madeline Lancaster and is headquartered in Vienna, Austria. | Directeur Général | 01/05/2019 |
Heartbeat.bio AG
 Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Fondateur | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
a:head bio AG
a:head bio AG Miscellaneous Commercial ServicesCommercial Services a:head bio AG engages in the research in as well as development and marketing of products in the pharmaceutical and biotechnology sectors. Its business activities focus on the development of new therapeutics for the treatment of brain disorders based on human cerebral organoids. The company was founded by Oliver Szolar, Jürgen Knoblich, and Madeline Lancaster and is headquartered in Vienna, Austria. | Commercial Services |
Heartbeat.bio AG
Heartbeat.bio AG Miscellaneous Commercial ServicesCommercial Services HeartBeat.bio AG is an Austrian company that specializes in developing a high-throughput human organoid screening platform for cardiac drug discovery. HeartBeat.bio is based in Vienna, AT, at the Biocenter. The company's technology platform is based on self-organizing, scalable cardiac organoids that replicate human heart physiology, allowing for modeling of various diseases such as drug-induced and genetic cardiomyopathies, myocardial infarction, heart remodeling, and regeneration. The company was founded in 2021 by a team with extensive experience in organoid research, drug discovery, and business development. Michael Krebs has been the CEO since incorporation. | Commercial Services |
